Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -1.84% is 97% above its 5-year average of -54.23%, near the high end of its 5-year range (-153.07%–10.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 84.72% above its 12-month average of -12.02%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -1.84%.
RETURN ON INVESTED CAPITAL (ROIC)
-1.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-12.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-11.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-54.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-57.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-69.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-86.35%
CURRENT VS TTM AVG
+84.72%
CURRENT VS 3Y AVG
+84.09%
CURRENT VS 5Y AVG
+96.62%
CURRENT VS 10Y AVG
+96.79%
CURRENT VS 15Y AVG
+97.36%
CURRENT VS 20Y AVG
+97.87%
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
+94.19%
vs the sector median at left
Fennec Pharmaceuticals Inc.
Market Cap
$357.44M
Return on Invested Capital (ROIC)
-1.84%
TTM Avg
-12.02%
3Y Avg
-11.54%
5Y Avg
-54.23%
Market Cap
$357.37M
Return on Invested Capital (ROIC)
-24.20%
TTM Avg
-33.45%
3Y Avg
-34.14%
5Y Avg
-28.75%
Market Cap
$359.05M
Return on Invested Capital (ROIC)
-59.29%
TTM Avg
-166.84%
3Y Avg
-79.03%
5Y Avg
-92.27%
Market Cap
$354.48M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$348.55M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$341.50M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$341.46M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$376.18M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-10.82%
3Y Avg
-40.29%
5Y Avg
-33.17%
Market Cap
$378.75M
Return on Invested Capital (ROIC)
-80.67%
TTM Avg
-59.31%
3Y Avg
-71.22%
5Y Avg
-64.55%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | $357.44M | -1.84% | -12.02% | -11.54% | -54.23% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.37M | -24.20% | -33.45% | -34.14% | -28.75% |
| Opus Genetics, Inc. (IRD)vs › | $359.05M | -59.29% | -166.84% | -79.03% | -92.27% |
| Embecta Corp. (EMBC)vs › | $354.48M | 17.99% | 23.20% | 26.35% | 40.47% |
| Agenus Inc. (AGEN)vs › | $348.55M | N/A | -35.18% | -129.73% | -103.61% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.50M | -27.16% | -54.52% | -49.44% | -51.83% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $341.46M | -40.51% | -48.13% | -48.38% | -39.85% |
| Canopy Growth Corporation (CGC)vs › | $376.18M | -10.85% | -10.82% | -40.29% | -33.17% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $378.75M | -80.67% | -59.31% | -71.22% | -64.55% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -85.56% | -114.55% | -77.72% | -63.50% |
ROIC
-1.8%
ROE
-7.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -1.84% |
| 2026-03-31 | -9.05% |
| 2025-12-31 | -10.55% |
| 2025-09-30 | -11.95% |
| 2025-06-30 | -26.70% |
| 2025-03-31 | -31.66% |
| 2024-12-31 | 6.63% |
| 2024-09-30 | 3.23% |
| 2024-06-30 | 10.59% |
| 2024-03-31 | 10.52% |
| 2023-12-31 | -66.13% |
| 2023-09-30 | -113.05% |
| 2023-06-30 | -153.07% |
| 2023-03-31 | -136.58% |
| 2022-12-31 | -101.16% |
| 2022-09-30 | -75.16% |
| 2022-06-30 | -125.16% |
| 2022-03-31 | -90.48% |
| 2021-12-31 | -82.96% |
| 2021-09-30 | -68.17% |
| 2021-06-30 | -66.19% |
| 2021-03-31 | -76.10% |
| 2020-12-31 | -61.52% |
| 2020-09-30 | -58.34% |
| 2020-06-30 | -39.30% |
| 2020-03-31 | -167.40% |
| 2019-12-31 | -109.55% |
| 2019-09-30 | -83.06% |
| 2019-06-30 | -81.61% |
| 2019-03-31 | -58.83% |
| 2018-12-31 | -48.84% |
| 2018-09-30 | -42.95% |
| 2018-06-30 | -36.84% |
| 2018-03-31 | -31.06% |
| 2017-12-31 | -25.98% |
| 2017-09-30 | -63.02% |
| 2017-06-30 | -40.91% |
| 2017-03-31 | -111.43% |
| 2016-12-31 | -80.42% |
| 2016-09-30 | -53.93% |
| 2016-06-30 | -44.06% |
| 2016-03-31 | -778.60% |
| 2015-12-31 | -344.89% |
| 2015-09-30 | -209.03% |
| 2015-06-30 | -216.82% |
| 2015-03-31 | -338.01% |
| 2014-12-31 | -469.33% |
| 2012-09-30 | -264.64% |
| 2012-06-30 | -181.52% |
| 2012-03-31 | -72.83% |
| 2010-09-30 | -59.57% |
| 2010-06-30 | -42783.58% |
| 2010-03-31 | -2902.13% |
| 2009-12-31 | -714.29% |
| 2009-09-30 | -953.73% |
| 2009-06-30 | -927.88% |
| 2009-03-31 | -689.36% |
| 2008-12-31 | -382.53% |
| 2008-09-30 | -250.71% |
| 2008-06-30 | -165.87% |
| 2008-03-31 | -122.83% |
| 2007-12-31 | -95.83% |
| 2007-09-30 | -94.44% |
| 2007-06-30 | -87.70% |
| 2007-03-31 | -85.29% |
| 2006-12-31 | -146.62% |
| 2006-09-30 | -90.60% |
| 2006-06-30 | -71.80% |
| 2006-03-31 | -81.96% |
| 2005-12-31 | -71.16% |
| 2005-09-30 | -12.89% |
| 2005-06-30 | -9.22% |
| 2005-03-31 | -2.09% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | -27.48% |
| 2004-06-30 | -23.38% |
| 2004-03-31 | -25.24% |
| 2003-12-31 | -20.95% |
| 2003-09-30 | -30.65% |
| 2003-06-30 | -26.73% |
